Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 42

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 42
---
 forward the purchased securities. If less than all of the warrants
represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.

Prior to the exercise of any warrants
to purchase common stock, holders of the warrants will not have any of the rights of holders of the common stock purchasable upon exercise,
including in the case of securities warrants for the purchase of common stock, the right to vote or to receive any payments of dividends
on the common stock purchasable upon exercise.

<div align='center'>DESCRIPTION OF UNITS</div>

As specified in the applicable
prospectus supplement, we may issue units consisting of shares of common stock or warrants or any combination of such securities.

The applicable prospectus supplement
will specify the following terms of any units in respect of which this prospectus is being delivered:

| ● | the terms of the units                                                                                                                     
 and of any of the common stock and warrants comprising the units, including whether and under what circumstances the securities comprising 
 the units may be traded separately;                                                                                                        |
| ● | a description of the terms                                                                                                                 
 of any unit agreement governing the units; and                                                                                             |
| ● | a description of the provisions                                                                                                            
 for the payment, settlement, transfer or exchange of the units.                                                                            |

<div align='center'>8

PLAN OF DISTRIBUTION</div>

We may sell the securities offered
through this prospectus (i) to or through underwriters or dealers, (ii) directly to purchasers, including our affiliates, (iii) through
agents, or (iv) through a combination of any these methods. The securities may be distributed at a fixed price or prices, which may be
changed, market prices prevailing at the time of sale, prices related to the prevailing market prices or negotiated prices. The prospectus
supplement will include the following information:

| ● | the terms of the offering;                                                                   |
| ● | the names of any underwriters or agents;                                                     |
| ● | the                                                                                          
 name or names of any managing underwriter or underwriters;                                   |
| ● | the                                                                                          
 purchase price of the securities;                                                            |
| ● | any                                                                                          
 over-allotment options under which underwriters may purchase additional securities from us;  |
| ● | the                                                                                          
 net proceeds from the sale of the securities;                                                |
| ● | any                                                                                          
 delayed delivery arrangements;                                                               |
| ● | any                                                                                          
 underwriting discounts, commissions and other items constituting underwriters’ compensation